La Roche-Posay AI Visibility Market Strategy Report - Dermatologist Recommended Skin Care Brands

Answer Capsule

La Roche-Posay is the strongest challenger in the dermatologist-recommended skin care category, holding 92.86% valid recommendation coverage in October 2026, 1.6 points behind category leader CeraVe. The brand converts near-universal presence into top-three placement at a 70.78% rate but converts to first-position recommendations at only 18.31%, a 52.47-point gap between shortlist inclusion and first-choice selection. The clearest win is the brand's 17.5-point top-three rate gain since July 2026. The clearest weakness is rank-one conversion. The clearest opportunity is closing the first-position gap in the Brand Recommendation cluster.

Who This Report Is For

This report is for La Roche-Posay brand leadership, dermatological marketing teams, and retail category managers evaluating how AI search and assistant platforms recommend dermatologist-recommended skin care brands at the discovery and consideration stage.

Report Card

Executive Summary

La Roche-Posay holds the second-strongest recommendation position in the dermatologist-recommended skin care category. The brand recorded 728 mentions across 770 qualified observations in October 2026, a raw mention presence rate of 94.55%, and converted 715 of those into valid recommendations, a valid recommendation coverage of 92.86%. The gap to CeraVe, the category leader at 94.55% coverage, is 1.6 points, nearly identical to the 1.6-point gap recorded at the July 2026 baseline.

The brand's recommendation profile is highly positive. Of 728 mentions, 718 were positive, 10 were neutral, and zero were negative, producing a net sentiment score of 0.9863. This is the highest net sentiment score among the top three brands by coverage. The framing quality of La Roche-Posay mentions is strong and consistent across the tracking period.

The strongest cluster is Brand Recommendation (C01), which captured all 770 qualified observations in October 2026. Within this cluster, La Roche-Posay recorded a top-three rate of 70.78% and a rank-one rate of 18.31%. The brand was recommended in the top three in 545 of 770 observations and was the first recommendation in 141. The average recommended rank was 2.46.

The weakest signal is rank-one conversion. While La Roche-Posay appears in the top three in more than seven of every ten qualified observations, it leads the recommendation in fewer than two of every ten. CeraVe, by contrast, holds a rank-one rate of 54.94%. The 36.63-point gap between the two brands on first-position recommendations is the largest single-metric gap between them.

The strongest platform signal is Google AI Overviews, where La Roche-Posay recorded a 93.30% valid recommendation coverage and a 27.32% rank-one rate across 185 observations. The brand also performed strongly on Google AI Mode, with 89.50% coverage and a 23.50% rank-one rate across 184 observations. These two platforms account for the majority of the brand's recommendation volume.

The clearest platform gap is Perplexity, where La Roche-Posay recorded an 89.47% valid recommendation coverage but a rank-one rate of only 5.26%. On ChatGPT, the brand recorded a 95.56% coverage rate but a rank-one rate of 18.89%. The pattern across platforms is consistent: La Roche-Posay is shortlisted frequently but selected first infrequently.

What La Roche-Posay Is Winning

Questions This Section Answers

• Where is La Roche-Posay strongest in AI-recommended skin care results?
• Which platforms and placement metrics show the clearest gains for La Roche-Posay?

La Roche-Posay holds the second-highest valid recommendation coverage in the category at 92.86%, trailing only CeraVe at 94.55%. The brand's coverage increased 3.8 points from the July 2026 baseline of 89.10%, matching CeraVe's 3.8-point gain over the same period.

The brand's top-three placement rate rose from 53.30% in July 2026 to 70.78% in October 2026, a 17.5-point gain. This is the second-largest top-three rate improvement among the top three brands, behind CeraVe's 20.2-point gain. In raw terms, La Roche-Posay was recommended in the top three in 545 of 770 qualified observations in October 2026, compared with 412 of 773 in July 2026.

La Roche-Posay recorded the highest net sentiment score among the top three brands by coverage, at 0.9863. The brand had zero negative mentions across 728 total mentions in October 2026. This indicates that when AI systems reference La Roche-Posay, the framing is overwhelmingly positive.

The brand's strongest platform by recommendation behavior is Google AI Overviews, where it recorded a 93.30% valid recommendation coverage and a 27.32% rank-one rate. This platform alone accounted for 173 valid recommendations and 51 rank-one placements across 185 observations.

Where La Roche-Posay Has the Clearest AI Visibility Gaps

Questions This Section Answers

• Why does La Roche-Posay appear in AI shortlists so often but rank first so rarely?
• Which data gaps limit what the benchmark can say about the decision stage?

The primary gap is rank-one conversion. La Roche-Posay holds a top-three rate of 70.78% but a rank-one rate of only 18.31%. This means the brand is included in the shortlist in more than seven of every ten qualified observations but is selected as the first recommendation in fewer than two. CeraVe, the category leader, holds a rank-one rate of 54.94%, a 36.63-point advantage.

This gap is consistent across platforms. On ChatGPT, La Roche-Posay recorded a 95.56% valid recommendation coverage but an 18.89% rank-one rate. On Copilot, coverage was 96.91% with a 7.22% rank-one rate. On Gemini, coverage was 95.74% with a 12.77% rank-one rate. On Perplexity, coverage was 89.47% with a 5.26% rank-one rate. On Google AI Mode, coverage was 89.50% with a 23.50% rank-one rate. On Google AI Overviews, coverage was 93.30% with a 27.32% rank-one rate.

The brand is present in nearly every relevant AI response but is not the default first choice. This pattern suggests that AI systems recognize La Roche-Posay as a valid option but do not consistently position it as the primary recommendation. The gap is not a visibility problem; it is a recommendation-conversion problem.

The second gap is the absence of qualified observations in the Pricing and Value and Multi-Brand Comparison clusters. All 770 qualified observations in October 2026 fell into the Brand Recommendation cluster. The benchmark does not yet contain data on how La Roche-Posay performs when buyers ask about cost, value, or direct brand comparisons. This limits the ability to assess the brand's competitive position at the decision stage.

Biggest Opportunity

Questions This Section Answers

• What measurable change in rank-one recommendations is realistic for La Roche-Posay?
• Which prompts carry the most weight for converting shortlist appearances into first-choice selections?

The clearest opportunity for La Roche-Posay is closing the rank-one conversion gap in the Brand Recommendation cluster. The brand already appears in the top three in 70.78% of qualified observations. The path from top-three inclusion to first-position recommendation is the single highest-leverage improvement available.

This opportunity is specific and measurable. If La Roche-Posay increased its rank-one rate from 18.31% to 30%, it would add approximately 90 first-position recommendations across the 770 qualified observations. This would not require additional presence or coverage; it would require converting existing shortlist appearances into first-choice selections.

The prompt examples in the dataset suggest that the Brand Recommendation cluster includes high-intent queries such as "What is the number one dermatologist recommended lotion?" and "What is the best skin moisturizer?" These are prompts where the first recommendation carries disproportionate weight. Improving rank-one performance on these prompt types is the most direct path to closing the gap with CeraVe.

Competitive Landscape

Questions This Section Answers

• How does La Roche-Posay compare with CeraVe on top-three, rank-one, average rank, and sentiment?
• Which brands follow CeraVe and La Roche-Posay, and how far behind are they in AI recommendation placement?

CeraVe holds the strongest recommendation-stage position in the dermatologist-recommended skin care category, with La Roche-Posay as the clear second. The two brands are separated by 1.6 points on valid recommendation coverage but by 36.63 points on rank-one rate, indicating that CeraVe converts shortlist appearances into first-choice selections far more effectively.

Average recommended rank covers rank-eligible recommendations only.

La Roche-Posay ranks second on top-three rate and second on rank-one rate, but the distance to CeraVe on rank-one is far larger than the distance on top-three. The brand's average recommended rank of 2.46 is the second-best in the category, behind CeraVe at 1.66. Vanicream, the third-ranked brand by coverage, holds a top-three rate of 32.47%, less than half of La Roche-Posay's rate.

Prompt Evidence

Questions This Section Answers

• What do the sample high-intent prompts show about La Roche-Posay's rank-one performance across platforms?
• Which prompt and platform combinations expose the largest first-position gaps?

Google AI Overviews / Brand Recommendation Prompt: "What is the number one dermatologist recommended lotion?" Result: La Roche-Posay was recommended in the top three in 78.87% of observations on this platform but held the first position in only 27.32%.

ChatGPT / Brand Recommendation Prompt: "What is the best skin moisturizer?" Result: La Roche-Posay recorded a 95.56% valid recommendation coverage on ChatGPT but a rank-one rate of only 18.89%, indicating frequent shortlist inclusion without first-choice selection.

Perplexity / Brand Recommendation Prompt: "What is the best lotion to heal eczema?" Result: La Roche-Posay appeared in 89.47% of qualified observations on Perplexity but was the first recommendation in only 5.26%, the lowest rank-one rate among the brand's tracked platforms.

Google AI Mode / Brand Recommendation Prompt: "What is the best hand soap for psoriasis?" Result: La Roche-Posay recorded an 89.50% valid recommendation coverage and a 23.50% rank-one rate on Google AI Mode, the second-highest rank-one rate among the brand's platforms.

What CiteWorks Studio Would Do Next

Phase 1: AI Visibility Market Discovery Audit Map La Roche-Posay's recommendation position across all six AI platforms, identifying the specific prompt patterns where the brand appears in the top three but not in the first position.

Phase 2: Recommendation Readiness Plan Prioritize the high-intent prompts where rank-one conversion is weakest, focusing on the Brand Recommendation cluster and the platforms where the gap is largest.

Phase 3: Owned Answer Layer Buildout Develop owned content that directly addresses the attributes AI systems associate with first-position recommendations in this category, including dermatologist endorsement signals and product-specific evidence.

Phase 4: Citation / Authority Layer Development Strengthen the public evidence layer by ensuring that dermatological review sites, retail pages, and editorial sources consistently position La Roche-Posay as a primary recommendation rather than a secondary option.

Phase 5: Monthly AI Visibility and Recommendation Tracking Track rank-one conversion rate, top-three rate, and coverage by platform on a monthly basis to measure progress against the CeraVe benchmark and identify emerging gaps.

Why This Matters

AI presence alone is not enough. La Roche-Posay appears in nearly every relevant AI response, but it is selected first in fewer than one in five. The difference between being shortlisted and being chosen is the difference between being considered and being bought.

The next move is targeted correction of the prompt, page, and citation layers that drive first-position recommendations. The brand does not need more visibility; it needs stronger recommendation conversion. That requires understanding which prompts, platforms, and sources are shaping the first-choice decision and addressing them directly.

Core Metrics

Sentiment Score

Questions This Section Answers

• What does La Roche-Posay's sentiment score actually measure?
• Why can high sentiment still fall short of first-position recommendation performance?

Sentiment Score = (positive mentions × 1 + neutral mentions × 0 + negative mentions × -1) / total mentions

For La Roche-Posay in October 2026: (718 × 1 + 10 × 0 + 0 × -1) / 728 = 0.9863.

This score matters because unclassified mention counts are misleading. A brand that appears frequently but is framed negatively or neutrally is not in the same position as a brand that appears frequently and is framed positively. Share of voice is a diagnostic metric, not a business KPI. A positive recommendation, a neutral reference, a cautionary mention, and a competitor-displaced mention are not equal.

Counting all mentions as wins is bad measurement. La Roche-Posay's 728 mentions include 10 neutral references that do not carry recommendation weight. The brand's 0.9863 sentiment score indicates that nearly all mentions are positive, but the score alone does not capture whether those positive mentions translate into first-position recommendations. Classified sentiment is required before interpreting AI visibility, and it must be read alongside recommendation placement metrics.

Sentiment by Platform

Questions This Section Answers

• Which platforms carry the strongest positive sentiment for La Roche-Posay?
• Where does sentiment stay positive even when first-position recommendations are weak?

Methodology

1. This report is a benchmark-based analysis of La Roche-Posay's AI recommendation position in the dermatologist-recommended skin care category. It is not a client result and does not imply that CiteWorks Studio caused any benchmark outcome.
2. The reporting month is October 2026. The baseline comparison month is July 2026.
3. Six AI platforms were tracked: ChatGPT, Copilot, Gemini, Perplexity, Google AI Overviews, and Google AI Mode.
4. The October 2026 measurement produced 770 qualified observations from 800 total prompt-surface observations. The July 2026 baseline produced 773 qualified observations from 800 total prompt-surface observations.
5. The competitor universe includes 10 brands: CeraVe, La Roche-Posay, Vanicream, Cetaphil, Neutrogena, Aveeno, EltaMD, SkinCeuticals, Eucerin, and Differin.
6. All 770 qualified observations in October 2026 fell into the Brand Recommendation cluster (C01). The Pricing and Value (C02) and Multi-Brand Comparison (C03) clusters contained zero qualified observations.
7. Stage 0 extraction retained the query, AI platform, answer, brand outcome, recommendation placement, sentiment, and, where exposed, citations or attributable evidence sources.
8. A mention is defined as any appearance of the brand in an AI response, regardless of whether the brand was recommended.
9. A valid recommendation is defined as an appearance in a valid recommendation shortlist, as marked by the dataset. Negative, neutral, cautionary, comparison-anchor, and listed-only mentions are not counted as valid recommendations unless the dataset explicitly marks them as valid.
10. The unique question count for October 2026 was 666. The unique question count for July 2026 was 671.
11. Brand-level percentages use the 770 qualified observations as the denominator in October 2026, not the 800 raw prompt-surface observations collected.
12. Month-over-month movement identifies changes worth investigating. It does not by itself establish the cause of those changes. Source presence is evidence about the information environment, not automatic proof that the source caused the recommendation.

See How AI Is Recommending Your Brand

The public benchmark shows where La Roche-Posay stands in AI recommendations across the dermatologist-recommended skin care category. A company-level AI visibility audit maps the specific prompts, platforms, competitors, and evidence sources that shape first-position recommendations for your brand. It turns the benchmark's directional signals into a prioritized action plan.